Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00100-X/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=271757280&_hsenc=p2ANqtz-8SsTTmo7DznyS_il7m0izvPjEa90kGyMpQ3pimuf954jOJop-Dv6FdebzvuDo_0rMrbzO7SLIUeo08PgBr01QP8augCQ&utm_content=271743104&utm_source=hs_email